Company Overview of ZAO "Tomskie Kletochnye Tekhnologii"
ZAO "Tomskie Kletochnye Tekhnologii" develops new and original treatment methods for cancer and tuberculosis. The company develops, manufactures, and sells auto vaccines based on autologous dendritic cells. ZAO "Tomskie Kletochnye Tekhnologii" was founded in 2007 and is based in the Russian Federation.
Founded in 2007
Key Executives for ZAO "Tomskie Kletochnye Tekhnologii"
ZAO "Tomskie Kletochnye Tekhnologii" does not have any Key Executives recorded.
Similar Private Companies By Industry
|Biomed Im. I.I. Mechnikova, AO||Europe|
|CJSC MFPDK BIOTEC||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact ZAO Tomskie Kletochnye Tekhnologii, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.